¿Es sodium dilauramidoglutamide lysine seguro durante el embarazo?
No harmonised CLP classification or SCCS/CIR reproductive safety assessment located in authoritative databases; no peer‑reviewed reproductive or developmental toxicity data identified during review. The substance is a high‑molecular‑weight, zwitterionic/peptidic surfactant‑type material and is expected to have negligible systemic absorption from typical topical cosmetic use, so reproductive hazard and mechanism are not indicated (sources checked: ECHA Annex VI, SCCS/CIR, PubMed, PubChem, CosIng, EWG).
Pregnancy-safe products containing sodium dilauramidoglutamide lysine










Related ingredients
Frequently asked questions
- ¿Es sodium dilauramidoglutamide lysine seguro durante el embarazo?
- No harmonised CLP classification or SCCS/CIR reproductive safety assessment located in authoritative databases; no peer‑reviewed reproductive or developmental toxicity data identified during review. The substance is a high‑molecular‑weight, zwitterionic/peptidic surfactant‑type material and is expected to have negligible systemic absorption from typical topical cosmetic use, so reproductive hazard and mechanism are not indicated (sources checked: ECHA Annex VI, SCCS/CIR, PubMed, PubChem, CosIng, EWG).
- ¿Es sodium dilauramidoglutamide lysine seguro durante la lactancia?
- No evidence of reproductive/breastfeeding risk or milk transfer data in regulatory assessments or peer‑reviewed literature. Given expected negligible dermal absorption and lack of systemic toxicity data, risk to lactation/breastfed infants is considered negligible (sources checked: CIR, SCCS, PubMed, ECHA, PubChem, CosIng, EWG).
- ¿Es sodium dilauramidoglutamide lysine seguro para la piel del bebé?
- No infant‑specific toxicology data found. Because the ingredient is a large, charged surfactant‑like molecule with likely low adult dermal absorption, hazard and mechanism remain unremarkable. Exposure score increased by +1 for babies (per instructions) to reflect higher exposure/absorption from immature infant skin; no data indicate developmental or reproductive toxicity in infants (sources: ECHA Annex VI, SCCS/CIR, PubMed, PubChem, CosIng, EWG).
- ¿Cómo puntúa VeriMom a sodium dilauramidoglutamide lysine?
- VeriMom puntúa sodium dilauramidoglutamide lysine en 100/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a sodium dilauramidoglutamide lysine en el embarazo?
- Consulta nuestra lista de alternativas seguras a sodium dilauramidoglutamide lysine según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.